ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. It is focused on developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceuticals. The company's areas of focus include developing and manufacturing complex dosage forms, including extended-release, and combination products, as well as products with difficult-to-source or controlled-substance active pharmaceutical ingredients (APIs). ANI aims to provide patients with affordable and accessible medicines, particularly in niche markets.
Serves as the primary corporate office, overseeing strategic operations, financial management, regulatory affairs, and corporate governance for the company's pharmaceutical development, manufacturing, and commercialization activities.
Located in a smaller, rural community, which is somewhat unique for a pharmaceutical company headquarters. This may reflect a commitment to local community or historical reasons for its establishment there. The Baudette site also includes significant manufacturing capabilities.
Likely a focused, collaborative environment typical of pharmaceutical companies, with an emphasis on quality, compliance, and innovation. Given its location, it might foster a close-knit community feel among employees, balanced with the rigor of a publicly-traded company.
The Baudette headquarters is central to ANI's identity and operations, housing key decision-making functions and supporting one of its primary U.S. manufacturing facilities.
While primarily focused on the U.S. market, ANI Pharmaceuticals has a significant manufacturing and development presence in Canada (Oakville, Ontario) through its subsidiary, ANI Pharmaceuticals Canada Inc. Its products are predominantly marketed and sold in the United States. The company sources raw materials and Active Pharmaceutical Ingredients (APIs) globally and may engage in partnerships that extend its reach indirectly to other markets for specific products or technologies.
210 Main Street West
Baudette
MN
USA
Address: 2800 Plymouth Drive, Oakville, Ontario, L6H 5R4 Canada
Serves as a critical node in ANI's North American manufacturing network, specializing in specific dosage forms and contributing to the company's supply chain resilience and market access in Canada.
Address: 120 & 140 New Canton Way, East Windsor, NJ 08520, USA
Focuses on product development, innovation, analytical testing, and supporting the pipeline of new generic and branded pharmaceuticals. Its proximity to other pharma companies and talent pools is advantageous for R&D and strategic partnerships.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, ANI Pharmaceuticals, Inc.' leadership includes:
ANI Pharmaceuticals, Inc. has been backed by several prominent investors over the years, including:
ANI Pharmaceuticals strengthened its leadership team over the past 12 months with key appointments in commercial operations, corporate development, and research & development, signaling a focus on growth, pipeline expansion, and strategic initiatives. No major publicly announced departures from the core executive team were noted during this period.
Discover the tools ANI Pharmaceuticals, Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
ANI Pharmaceuticals commonly uses the email format 'first.last@anipharmaceuticals.com' for its employees. Another potential format, though less confirmed, might be 'firstinitiallast@anipharmaceuticals.com'. For official inquiries, it is always best to use contact forms or email addresses provided on their official website.
first.last@anipharmaceuticals.com
Format
jane.doe@anipharmaceuticals.com
Example
75%
Success rate
Business Wire • May 21, 2024
ANI Pharmaceuticals received FDA approval for its New Drug Application for Cortrophin® Gel (Repository Corticotropin Injection USP) Lyophilized Powder for Reconstitution. This new formulation aims to enhance patient convenience and expand treatment options, potentially offering a longer shelf life and simplified preparation....more
Business Wire • May 7, 2024
ANI Pharmaceuticals announced record financial results for the first quarter of 2024, driven by strong net revenue growth from its Cortrophin Gel and generic products. The company also raised its full-year 2024 financial guidance, reflecting confidence in continued strong performance....more
GlobeNewswire • February 27, 2024
ANI Pharmaceuticals reported record net revenues for both the fourth quarter and full-year 2023, exceeding prior guidance. The growth was largely attributed to the performance of Purified Cortrophin™ Gel and the Rare Disease franchise....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including ANI Pharmaceuticals, Inc., are just a search away.